Abstract
Head and neck squamous cell carcinoma (HNSCC) is a major cause of morbidity and mortality in cancer patients worldwide. Most patients with HNSCC are diagnosed with locally advanced disease, and treated with cisplatin-based chemoradiation, but long-term disease control is still a challenge. The incorporation of epigenetic regulation into standard treatment could improve results of definit…